Trust me, if "cancer" was "cured", the entire pharmaceutical / biotech industry would heave a collective sigh of relief. From a profitiability standpoint, obesity, heart-disease, erectile dysfunction, and hair loss are much larger and more lucrative markets, and with the "big C" out of the way so to speak, research dollars would be directed en masse towards those efforts. Considering most cancer therapies enter the market for treating late-stage patients (ie terminal cancer) due to FDA requirements for clinical trials, the myth that pharma companies want to keep cancer patients alive as "cash cows" is completely ridiculous.
Here's a real-world example from the inside of the industry. Up until about a month ago, I managed a research informatics department for a biotech company. The focus of the site I worked at was Cystic Fibrosis. At this time, there is no cure for CF, but the drug developed by my company (at the time, as very small biotech company) was the most effective therapy for treating the primary complication of CF ->
Pseudomonas aeruginosa infections of mucous that would accumulate in patient's lungs due to complications of CF. 10 years ago, the life expectancy of a person who developed CF was late teens, early 20's...that is now up to 35. That's not entirely due to the my company's product, but it does play a large part in that. The work we did solving the genome of this organism is now in the public domain ->
www.pseudomonas.com . ANY company or research organization that wants to use this work is free to, in fact they are encouraged to.
About a year ago, 2 service techs from the compressed gas company that we use at our site were walking down the hall outside my office. I had a large circular map of the
P.aeruginosa genome on the wall outside my office, and i could hear them trying to figure out what it was. Since it was my group and my company that sequenced the
P.aeruginosa genome in the late 90's, I stepped out of my office and explained what it was, and that it was this organism that caused a large number of complications for CF patients and that our company had not only sequenced the genome, but had developed the leading pharmaceutical for CF patients.
As soon as the words Cystic Fibrosis came out of my mouth, I could see that one of the guys demeanor had changed. He told me that his 3month old daughter had just been diagnosed with CF a week before. He was noticeably upset, even though his daughter's physician had assured him that the treatments had advanced and that she should live a long full life despite her disease. I spent about an hour with him, showing him resources on how biotech and pharma companies were committed to not just treating symptoms, but finding cures for this disease....a relatively small market disease at that. He left that day much more confident and with a solid understanding of his daughters disease, and what to expect, and with the solid understanding that there are hundreds, if not thousands of people working to make her life better.
I still correspond with him, even though I no longer work for that company. His daughter is doing great, she's responding to mild therapy and shows no outward symptoms of respiratory distress.
THAT is why I work in this industry.
http://en.wikipedia.org/wiki/Cystic_fibrosishttp://www.pseudomonas.com/Who do those billions get passed on to?
Lots of places. Companies that develop instruments, contract research organizations, salaries like mine, computer hardware / software companies, lawyers, local businesses that supply material goods and services, etc. Just like any large development effort, the dollars spent are diverse and affect the local economy surrounding the facilities.
Why don't those pharma companies do the kind-hearted thing and eat all those costs so they can save a few lives?
Trust me, they minimize costs as much as they can. They are in the business of being in business, however, if the company invests billions and goes out of business, how does that benefit the patient? You may not realize that the majority of those costs are to conduct clinical trials to satisfy the requirements of the FDA for safety and effectiveness. Sure, eating the costs <might> "save a few lives", but building a sustainable business will save many-fold more.
If I didn't know better, boykster coulda been talking about the oil industry 
I agree.